Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
StockCIK 1837607

AEON Biopharma, Inc. (AEON): Insider Trades and Fund Holdings

In the past 12 months, AEON Biopharma, Inc. insiders reported 1 open-market purchase worth $243K and 0 sales worth $0.

1Insider buys, 12 months
$243KBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Aug 21, 2026.

Recent AEON insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Aug 21Aug 19Timothy P. Lynch10% owner10% owner▲ BUY1,150,0000.2117$243K+22%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Timothy P. Lynch10% owner1$243K0$0Aug 21, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →